QUALITY OF LIFE – AN IMPORTANT ENDPOINT OF TREATMENT IN PATIENTS WITH HEART FAILURE
Heart failure (HF) is a heterogeneous syndrome, with progressive evolution and negative impact on quality of life and mortality of patients. The incidence of HF in Europe and the United States of America varies between 1 to 9 cases per 1000 inhabitants, depending on the population studied and t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Balkan Medical Union
2022-09-01
|
| Series: | Archives of the Balkan Medical Union |
| Subjects: | |
| Online Access: | https://doi.org/10.31688/ABMU.2022.57.3.219 |
| Summary: | Heart failure (HF) is a heterogeneous syndrome,
with progressive evolution and negative impact on
quality of life and mortality of patients. The incidence
of HF in Europe and the United States of
America varies between 1 to 9 cases per 1000 inhabitants,
depending on the population studied and the
diagnostic criteria used1. Currently, it is estimated
that approximately 64.3 million people suffer from
HF world-wide2.
One of the most important therapeutic goals for
patients with HF is represented by maintaining and
improving the quality of life. Many patients value
functional status and quality of life more than longevity.
The most important predictors of the quality
of life in HF are the presence of symptoms and their
severity, functional status and depression3. Current
guidelines recommend the combined use of medical
and behavioural interventions to improve the functional
status of these patients. |
|---|---|
| ISSN: | 1584-9244 2558-815X |